
URGN vs PCRX
$URGN vs $PCRX head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
URGN vs PCRX: trend, levels and the market
One year to 2026-11-16, against the S&P 500 (+11.7%). Split-adjusted daily closes.
- ·Their trends point opposite ways: PCRX is above both its 50- and 200-day averages while URGN is below both.
- ·Only PCRX beat the market over the past year, by 38.3%, while URGN trailed the S&P 500 at +11.7% by 0.5%.
- ·PCRX sits closer to its support, 0.1% above it at $36.43, while URGN is 27.2% above its own at $23.10.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
URGN vs PCRX: the quick read
- ·PCRX is the larger company by market cap ($1.46B vs $1.46B).
- ·URGN has been more active on our scanner (189 vs 1 alerts in 30 days).
- ·PCRX has the smaller float (37.1M vs 47.1M), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·URGN draws far more of our scanner's attention, 189 unusual-volume alerts in 30 days against 1, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 0% of each other on market cap, which makes the rest of this table the interesting part.
- ·They are pulling apart today: URGN is outperforming the other by roughly 6.4 percentage points on the session.
Objective differences only. Not investment advice.
Watching URGN or PCRX? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing URGN and PCRX on TheDesperateTrader.
- Is URGN or PCRX the better stock?
- "Better" depends on your goal, and these two are not alike. PCRX is the larger company by market cap ($1.46B vs $1.46B). URGN has been more active on our scanner (189 vs 1 alerts in 30 days). PCRX has the smaller float (37.1M vs 47.1M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between URGN and PCRX?
- The differences that matter: they are similar in size ($1.46B vs $1.46B); they trade at very different share prices ($31.73 vs $36.48); URGN sits at 44% of its 52-week range against 99% for PCRX; our scanner flagged URGN 189 times in the last 30 days against 1 for PCRX. Everything above is measured from the latest completed session and SEC filings.
- Which of URGN and PCRX is more active right now?
- Neither is showing unusual volume on the latest session, so nothing here is being driven by a volume spike. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is URGN or PCRX in the stronger trend?
- URGN is below its 50-day average of $36.68 and below its 200-day average of $31.73; PCRX is above its 50-day average of $31.39 and above its 200-day average of $25.73. PCRX leads 5 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading URGN or PCRX? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore URGN and PCRX comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.